Blueshift Asset Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $717K | Buy |
2,496
+799
| +47% | +$230K | 0.22% | 118 |
|
|
2025
Q1 | $523K | Buy |
+1,697
| New | +$523K | 0.21% | 148 |
|
|
2024
Q1 | – | Sell |
-1,983
| Closed | -$436K | – | 380 |
|
|
2023
Q4 | $436K | Buy |
+1,983
| New | +$436K | 0.23% | 126 |
|
|
2023
Q3 | – | Sell |
-1,458
| Closed | -$322K | – | 433 |
|
|
2023
Q2 | $322K | Buy |
1,458
+42
| +3% | +$9.27K | 0.12% | 205 |
|
|
2023
Q1 | $317K | Buy |
+1,416
| New | +$317K | 0.13% | 212 |
|
|
2021
Q4 | – | Sell |
-3,924
| Closed | -$724K | – | 1237 |
|
|
2021
Q3 | $724K | Buy |
3,924
+1,202
| +44% | +$222K | 0.04% | 512 |
|
|
2021
Q2 | $488K | Buy |
+2,722
| New | +$488K | 0.03% | 573 |
|
|
2019
Q3 | – | Sell |
-5,203
| Closed | -$406K | – | 972 |
|
|
2019
Q2 | $406K | Buy |
+5,203
| New | +$406K | 0.05% | 455 |
|